Share This Article:

Spontaneous Regression of a Histologically Proven Cutaneous Squamous Cell Carcinoma

Abstract Full-Text HTML XML Download Download as PDF (Size:201KB) PP. 546-548
DOI: 10.4236/jct.2013.42068    3,706 Downloads   5,428 Views  

ABSTRACT

Introduction: The rate of squamous cell carcinoma spontaneous regression (SR) remains unknown because incidences are rare and underreported. Case Report: We present a case of a 92-year-old Caucasian female who was found to have a 1 cm lesion on her nose. Pathologic evaluation supported the diagnosis of a moderately-differentiated squamous cell carcinoma. The patient refused treatment and returned with no clinical evidence of disease several months later. The lesion spontaneously regressed without excision. Discussion: Frequency of SR of malignancies has been estimated to occur 1 in 80,000 to 100,000 cases [1]. The biologic mechanisms of SR in malignancies remain unclear. Further investigations into the mechanisms of SR may identify potential treatment strategies for cancer.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

S. Sengupta, J. Arocho and T. Christopher Windham, "Spontaneous Regression of a Histologically Proven Cutaneous Squamous Cell Carcinoma," Journal of Cancer Therapy, Vol. 4 No. 2, 2013, pp. 546-548. doi: 10.4236/jct.2013.42068.

References

[1] G. B. Challi and H. J. Stam, “The Spontaneous Regression of Cancer: A Review of Cases from 1900 to 1987,” Acta Oncologica, Vol. 29, No. 5, 1990, pp. 545-550. doi:10.3109/02841869009090048
[2] F. H. Igney and P. H. Krammer, “Immune Escape of Tumors: Apoptosis Resistance and Tumor Counterattack,” Journal of Leukocyte Biology, Vol. 71, No. 9, 2002, pp. 907-920.
[3] Z. C. Ding and G. Zhou, “Cytotoxic Chemotherapy and CD4+ Effector T Cells: An Emerging Alliance for Durable Anti-Tumor Effects,” Clinical Development. Immunology, Vol. 2012, 2012, Article ID: 890178. doi:10.1155/2012/890178
[4] R. J. Papac, “Spontaneous Regression of Cancer,” Cancer Treatment Reviews, Vol. 22, No. 6, 1996, pp. 395-423. doi:10.1016/S0305-7372(96)90023-7
[5] W. Y. Chang, “Complete Spontaneous Regression of Cancer: Four Case Reports, Review of Literature, and Discussion of Possible Mechanisms Involve,” Hawaii Medical Journal, Vol. 59, 2000, pp. 379-385.
[6] B. O’Regan and C. Hirschberg, “Spontaneous Remission. An Annotated Bibliography,” Institute of Noetic Sciences, Sausalito, 1996.
[7] J. Li, K. Wang, T. D. Jensen, S. T. Li, P. M. De Angelis, S. Kolvraa, C. Proby, O. Forslund, L. Bolund and O. P. Clausen, “Array Comparative Genomic Hybridization of Keratoacanthomas and Squamous Cell Carcinomas: Different Patterns of Genetic Aberrations Suggest Two Distinct Entities,” Journal of Investigative Dermatology, Vol. 132, No. 8, 2012. doi:10.1038/jid.2012.104
[8] S. D. Cline and P. C. Hanawalt, “Who’s on First in the Cellular Response to DNA Damage?” Nature Reviews Molecular Biology, Vol. 4, No. 5, 2003, pp. 361-373. doi:10.1038/nrm1101
[9] F. J. Tefany, R. Barneston and C. Sta, “lmmunocytochemical Analysis of the Cellular Infiltrate in Primary Regressing and Non-Regressing Malignant Melanoma,” Journal of Investigative Dermatology, Vol. 97, No. 2, 1991, 197-202. doi:10.1111/1523-1747.ep12479662
[10] L. Jennings and C. D. Schmults, “Management of HighRisk Cutaneous Squamous Cell Carcinoma,” Journal of Clinical Aesthetic Dermatology, Vol. 3, No. 4, 2010, pp. 39-48.
[11] S. Mocellin, E. Wang and F. Marincola, “Cytokines and Immune Response in Tumor Microenvironment,” Journal of Immunotherapy, Vol. 24, No. 5, 2001, pp. 392-407. doi:10.1097/00 002371-200109000-00002
[12] S. J. Kalapurakai, J. Malone, K. Robbins, L. Beuscher, J. Godwin and K. Rao, “Cetuximab in Refractory Skin Cancer Treatment,” Journal of Cancer, Vol. 3, 2012, pp. 257-261. doi:10.7150/jca.3491
[13] M. Mancuso, D. Gallo, S. Leonardi, M. Pierdomenico, E. Pasquali, I. De Stefano, S. Rebessi, M. Tanori, G. Scambia1, V. Di Majo, V. Covelli, S. Pazzaglia and A. Saran, “Modulation of Basal and Squamous Cell Carcinoma by Endogenous Estrogen in Mouse Models of Skin Cancer,” Carcinogenesis, Vol. 30, No. 2, 2009, pp. 340-347. doi:10.1093/carcin/bgn243

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.